VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,646,033 | -50.8% | 223,683 | -36.1% | 0.00% | 0.0% |
| Q2 2023 | $7,404,623 | +23.1% | 350,266 | +17.0% | 0.00% | 0.0% |
| Q1 2023 | $6,012,916 | +12.5% | 299,448 | +46.4% | 0.00% | 0.0% |
| Q4 2022 | $5,343,585 | -31.9% | 204,500 | -73.4% | 0.00% | -50.0% |
| Q3 2022 | $7,845,000 | +3182.4% | 767,560 | +1247.8% | 0.00% | – |
| Q2 2022 | $239,000 | +223.0% | 56,949 | +282.2% | 0.00% | – |
| Q1 2022 | $74,000 | -55.2% | 14,900 | -39.4% | 0.00% | – |
| Q4 2021 | $165,000 | +32.0% | 24,589 | +7.5% | 0.00% | – |
| Q3 2021 | $125,000 | +26.3% | 22,870 | +93.8% | 0.00% | – |
| Q1 2021 | $99,000 | -47.6% | 11,800 | -56.1% | 0.00% | – |
| Q4 2020 | $189,000 | +177.9% | 26,900 | +148.5% | 0.00% | – |
| Q1 2019 | $68,000 | – | 10,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |